Significant segment expenses and loss before income taxes - Schedule of significant segment expenses (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
segment
|
Jun. 30, 2025
USD ($)
|
|
| Significant segment expenses | ||||
| Number of reportable segments | segment | 1 | |||
| Research and development | ||||
| Total research and development | $ 3,478 | $ 2,320 | $ 5,579 | $ 4,647 |
| General and administrative | ||||
| Total general and administrative | 1,907 | 1,981 | 3,831 | 3,540 |
| Total operating expenses | 5,385 | 4,301 | 9,410 | 8,187 |
| Loss from operations | (5,385) | (4,301) | (9,410) | (8,187) |
| Total other income | 69 | 306 | 271 | 521 |
| Loss before income taxes | (5,316) | (3,995) | (9,139) | (7,666) |
| Single reportable segment | ||||
| Research and development | ||||
| Direct costs - Vanoglipel | 235 | 277 | 402 | 568 |
| Direct costs - DA-1726 | 2,717 | 1,529 | 4,164 | 3,008 |
| Direct costs - Other R&D | 40 | 30 | 53 | 55 |
| Indirect costs - Employee compensation and benefits | 439 | 441 | 880 | 950 |
| Indirect costs - Consulting | 47 | 43 | 80 | 66 |
| Total research and development | 3,478 | 2,320 | 5,579 | 4,647 |
| General and administrative | ||||
| Legal and professional fees | 985 | 1,074 | 1,910 | 1,907 |
| Consulting | 204 | 230 | 451 | 333 |
| Employee compensation and benefits | 471 | 444 | 997 | 951 |
| Other G&A | 247 | 233 | 473 | 349 |
| Total general and administrative | 1,907 | 1,981 | 3,831 | 3,540 |
| Total operating expenses | 5,385 | 4,301 | 9,410 | 8,187 |
| Loss from operations | (5,385) | (4,301) | (9,410) | (8,187) |
| Total other income | 69 | 306 | 271 | 521 |
| Loss before income taxes | $ (5,316) | $ (3,995) | $ (9,139) | $ (7,666) |
| X | ||||||||||
- Definition The amount of expense provided in the period for consultancy services incurred in General and administrative. No definition available.
|
| X | ||||||||||
- Definition The amount of expense provided in the period for consultancy services incurred in Research and development. No definition available.
|
| X | ||||||||||
- Definition The amount of expense provided in the period for labor and related services incurred in General and administrative. No definition available.
|
| X | ||||||||||
- Definition The amount of expense provided in the period for labor and related services incurred in Research and development. No definition available.
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs and professional costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred in the first clinical trial program associated with research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred in the second clinical trial program associated with research and development. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|